medigraphic.com
ENGLISH

Medicina Crítica

  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • Políticas
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2002, Número 5

<< Anterior Siguiente >>

Med Crit 2002; 16 (5)


La importancia de la energía en el estado de choque y sepsis

Pérez CR
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 44
Paginas: 165-169
Archivo PDF: 59.25 Kb.


PALABRAS CLAVE

Choque, sepsis, hipoperfusión, trifosfato de adenosina, disfunción orgánica múltiple.

RESUMEN

La hipoperfusión produce hipoxia y descenso del trifosfato de adenosina (ATP) en sepsis y choque. Simultáneamente el requerimiento de energía para la protección de las células aumenta. La restauración adecuada del volumen intravascular y la presión arterial no es suficiente para evitar el daño celular durante el periodo de hipotensión y se puede desarrollar disfunción orgánica múltiple. En este número se revisó los efectos del ATP sobre la función celular y los resultados clínicos del empleo de ésta en el tratamiento de la hipoperfusión. La ATP-Mg.Cl2 puede incrementar el gasto cardíaco y el flujo coronario y disminuir el consumo de oxígeno sin producir hipotensión arterial.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bauve AE, Chaudry IH. Prevention of multiple system failure. Surg Clin North Am 1980;60:1167-1178.

  2. Border J, Hassett J, LaDuca J et al. The gut origin of septic state in blond multiple trauma (155-40) in the ICU. Ann Surgery 1987;206:427-448.

  3. Faist E, Bauwen AE, Dittmer H et al. Multiple organ failure in politrauma patients. J Trauma 1983;23:775-787.

  4. Cerra FB, Siegel JH, Border J et al. Correlations between metabolic and cardiopulmonary measurements in patients after trauma, general surgery and sepsis. J Trauma 1989; 19:621-628.

  5. Chaudry IH. Cellular mechanisms in shock and ischemia and their corrections. Am J Physiol 1985;245:R117-R143.

  6. Raskin MC, Bosken C, Baugman RP. Oxygen delivery in critically ill patients: relationship to blood lactate and surviver. Chest 1985;87;580-84.

  7. Dautzler D. Oxygen delivery and utilization in sepsis. Crit Care Clin 1990;5:81-98.

  8. Horkema JM, Dean RE, Stephan RN et al. Cellular dysfunction in sepsis. J Critical Care 1990;5:62-69.

  9. Chaudry IH, Sayeed MM, Bone AE. Alterations in high energy phosphate in hemorrhagic shock as related to tissue and organic function. Surgery 1986;79:666-68.

  10. Swort CJ, Rowlonds SD. Oxygen consumption and hepatic metabolism in experimental post-hemorrhagic shock. J Trauma 1992;12:327-334.

  11. Bave AE, Wurth MA, Sayeed MM. The dynamics of altered ATP-dependent and ATP-yielding cell process in shock. Surgery 1992;72:94-101.

  12. Rhodes RS, De Palma GR. Mitochondrial dysfunction of the liver and hypoglycemia in hemorrhagic shock. Surgery Gynecol Obstet 1990;1560:347-52.

  13. Huckabee WE. Abnormal resting blood lactate. II lactatic acidosis. Am J Med 1991;30:840-848.

  14. Schumer W. Localization of the energy pathway bock in shock. Surgery 1994;64:55-59.

  15. Shibutani K, Komatsu T, Kubal F et al. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1993;11:640-43.

  16. Maclean LD, Mulligan W, Mclean AP et al. Patterns of septic shock in man-detailed study of 56 patients. Ann Surg 1992;116:543-63.

  17. Biharg D, Smithles M, Ginson A et al. The effects of vasodilatation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987;317:397-403.

  18. Grum C, Simon R, Dantzker D et al. Evidence for adenosine triphosphate degradation in critically ill patients. Chest 1988;88:763-67.

  19. Schumer W, Das Gueta TK, Moss GS et al. Effect of endotoxemia on liver cell mitochondria in man. Ann Surg 1990;171:875-82.

  20. Dawson KL, Geller ER, Kirkpatrick JR. Enhancement of mitochondrial function in sepsis. Arch Surg 1988;123:241-244.

  21. Chaudry IH, Wichterman KA, Bave AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1991;85:205-211.

  22. Haybron DM, Townsend MC, Hampton WA et al. Alterations in renal perfusion and renal energy charge in murine peritonitis. Arch Surg 1989;122:328-331.

  23. Pasque MK, Murphy CE, Tright PV et al. Myocardial adenosine triphosphate levels during early sepsis. Arch Surg 1989;118:1437-40.

  24. Chaudry IH, Sayeed MM, Bave AE. Effect of adenosine triphosphate magnesium chloride administration in shock. Surgery 1993;75:220-227.

  25. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery 1991; 101:1.

  26. Border Jr, Hassett J, La Duca J et al. The gut origin septic states in blunt multiple trauma (155 = 40) in the ICU. Ann Surg 1993;206:427.

  27. Moore FA, Moore EE, Jones TN et al. TEN versus TPN following major abdominal trauma reduced septic morbidity. J Trauma 1990;29:916.

  28. Moore FA, Feliciano DV, Andrassy RJ et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications the results of a meta-analysis. Ann Surg 1992;216:172.

  29. Alverdy J, Chi HS, Sheldon GF. The affect of parenteral nutrition on gastrointestinal immunity. Ann Surg 1994;202:681.

  30. Piccone VS, Leveen HH, Glass P. Prehepatic hyperalimentation. Surgery 1995;87:263.

  31. Barton RG, Wells CL, Carlson A et al. Dietary W-3 fatty acids decrease mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis. J Trauma 1991;31:768.

  32. Bell RC, Coalson JJ, Smith JD et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1993;99:293.

  33. Beather B, Cerami AC. More than a tumor necrosis factor. N Engl J Med 1987;316:379.

  34. Bihori D, Tinker J. The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis. Intensive Care Med 1988;15:2.

  35. Bone RC, Slotwan G, Maunder R et al. Randomized double-blind, multicenter study of prostaglandin E1, in patients with the adult respiratory distress syndrome. Chest 1991-1996:114.

  36. Buchman TG, Cabin DE, Buckley GB et al. Molecular-biology of circulatory shock II, expression of four groups of hepatic genes is enhanced following resuscitation from cardiogenic shock. Surgery 1990;108:902.

  37. Caty MG, Guice KS, Kankel SF et al. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990;212:694.

  38. Dahn MS, Lange P, Lobdell et al. Splanchnic and total body oxygen consumption in septic and injured patients. Surgery 1995;101:69.

  39. Faist E, Bave AE, Dittmer H et al. Multiple organ failure in polytrauma patients. J Trauma 1994;23:775.

  40. Fry DE, Pearlstein L, Fulton RL et al. Multiple system organ failure. The role of occult infection. Arch Surg 1994; 115:136.

  41. Goris RJA, Boekhorst TPA, Nuytinck JKS et al. Multiple organ failure. Generalized autodestruction inflammation? Arch Surg 1993;120:1109.

  42. Haupt MJ, Jastremski MS, Clemmer TP et al. And the ibuprofen study group: effect of I ibuprofen in patients with severe sepsis. A randomized double-blind, multicenter study. Crit Care Med 1993;14:1339.

  43. Heath MF, Fighe D, Moss R et al. Relevance of serum phospholipase A2 assays to the assesment of septic shock. Crit Care Med 1994;18:766.

  44. Krause CS, White BC, Kumar K et al. Brain cell death following ischemia and reperfusion: Proposed biochemical sequence. Crit Care Med 1993;16:714.










2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2002;16

ARTíCULOS SIMILARES

CARGANDO ...